Skip to main content
. 2019 Feb 10;9(5):1021–1034. doi: 10.1016/j.apsb.2019.02.001

Figure 5.

Fig. 5

Inhibition of tumour growth in vivo by MCC1019. (A) LLC-1 lung tumor bearing mice and RM-1 prostate tumor bearing mice models were used to determine the in vivo anti-tumor efficacy of MCC1019. (B) Total animal body weight changes were monitored after treatment with MCC1019 in both models. (C) Tumors and organs weight changes after MCC1019 treatment in LLC-1. The data are represented as mean ± SD (n = 6–8/group).